cardiac patients (coronary artery disease, dilated cardiomyopathy, hypertrophic cardiomyopathy, valvular disease, myocardial infarction)
Conditions
Interventions
None listed
Sponsors
Gifu University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Cardiac patents (coronary artery disease, dilated cardiomyopathy, hypertrophic cardiomyopathy, valvular heart disease, myocardial infarction) Patients with written informed consent
Exclusion criteria
Exclusion criteria: patients judged as inappropriate by the doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the relationship between plasma microRNA145, microRNA143, progranulin, exosome and cardiac function | — |
Countries
Japan
Contacts
Public ContactShinya Minatoguchi
Gifu University Department of Circulatory and Respiratory Advanced Medicine
Outcome results
None listed